Skip to main content

Epidemiology of carbapenem-resistant Klebsiella pneumoniae ST15 of producing KPC-2, SHV-106 and CTX-M-15 in Anhui, China



It is well known that carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a more problematic public health issue due to its widespread spread worldwide. In China, ST11-type CRKP is the most prevalent CRKP, but ST15-type CRKP, a recently prevalent high-risk clone, has emerged widely throughout China, posing a serious public health risk. Therefore, we conducted an epidemiological of an outbreak of ST15 CRKP of producing CTX-M-15, KPC-2 and SHV-106 in a tertiary hospital in Anhui, China, to Understanding the potential risks of the current STT15 CRKP outbreak.


From July 2021 to December 2021, 13 ST15 CRKP isolates were identified by collecting non-repeated clinical multidrug-resistant isolates, with all capsular typing of serotype KL19. All ST15 CRKP isolates were resistant to cephalosporins, carbapenems and quinolones, but were sensitive to amikacin, tigecycline and polymyxin B. In addition, isolates carried blaSHV−106 (100%), blaKPC−2 (69%), blaCTX−M−15 (69%), blaTEM−1B (69%), blaOXA−1 (62%) and blaLAP−2 (8%), as well as iron chelators (iutA, ybt, fyuA, ent, fepA, irp1, irp2, 100%) were detected. In phenotyping experiments, all ST15 CRKP exhibited lower growth rates than NTUH-K2044, and all ST15 CRKP did not exhibit mucoviscositty characteristics. However, in the Galleria mellonella infection model, isolates 21081212, 21081241 and 21091216 were more lethal than the hypervirulent isolates NTUH-K2044. Sequencing results showed that the genetic environment surrounding the genes blaSHV−106, blaKPC−2, blaCTX−M−15, blaOXA−1 and blaTEM−1B were all identical in the ST15 CRKP isolates. Phylogenetic analysis showed that 13 ST15 CRKP isolates were divided into three subgroups, and when placed in global analysis, 10 of them were highly homologous to isolates from Jiangsu, two were highly homologous to isolates from Zhejiang, and one was homologous to an isolate from an unlabelled region.


Our research shows that ST15 CRKP, which carries multiple β-lactamases genes and siderophores-encoding genes, may be evolving to hypervirulence and may have spread widely in localised areas. Therefore, environmental surveillance and clinical infection control in hospitals should be strengthened to prevent further spread of ST15 CRKP.

Peer Review reports


One of the most prevalent nosocomial infections globally, Klebsiella pneumoniae is an Enterobacteriaceae bacterium that frequently infects elderly patients, patients in intensive care units and immunocompromised patients in hospitals [1]. In recent years, the prevalence of resistant K. pneumoniae has become more widespread due to the overuse of antibiotics, leading to the emergence of multidrug-resistant (MDR) isolates through the acquisition of different resistance genes during the transmission process [2]. Subsequently, carbapenems (e.g. imipenem, meropenem and doripenem) have become the last line of defense in the treatment of K. pneumoniae infections [3]. Unfortunately, due to the spread of mobile genetic elements has led to a steady increasing in CRKP [4]. The World Health Organisation (WHO) issued a report in 2017 highlighting the serious threat posed by carbapenem-resistant K. pneumoniae (CRKP) [5]. According to the data from China antibiotic resistance surveillance system (, the average detection rate of CRKP in China was 10.9% in 2020, and the detection rate reached more than 30% in some areas, and the trend is slowly increasing. In addition, CRKP infections have led to increased treatment difficulties with mortality rates as high as 40–50%, which poses a significant public health challenge [6].KPC-type β-lactamase is one of the important carbapenemases of CRKP and is widely seen in clinical conditions [7]. In China, a study showed that the sequence type of CRKP is predominantly the KPC-producing ST11 type [8]. ST15 K. pneumoniae is an emerging high-risk clonal isolate with frequent hospital outbreaks and has emerged carrying virulence-resistant heterozygous plasmids and ESBL genes [9]. CTX-M-15 β-lactamase, on the other hand, poses a significant threat to most antibiotics, especially cephalosporins [10]. SHV-type β-lactamases are thought to be present in isolates with little effect [11]. SHV-106-type β-lactamase was first reported in Portugal in 2009 [12]. Location-specific outbreaks of carbapenemase and β-lactamases carrying associated ST15 K. pneumoniae may be highly homologous. Still, the variability in antibiotic resistance of ST15 K. pneumoniae isolates from different study sites suggests that the potential for ST15 K. pneumoniae to acquire different resistance genes is substantial [13].

Here, we aimed to phenotypically and genomically characterise ST15 CRKP collected from a tertiary hospital in Anhui, China, to further explore the potential risk of ST15 CRKP outbreaks, including antibiotic resistance, virulence, etc.


Clinical characteristics

According to multilocus-sequence typing (MLST) and capsular typing, 13 clinical isolates of K. pneumoniae were ST15-type and all were serotype KL19. Thirteen isolates of ST15 CRKP were from sputum (n = 7), blood (n = 4), urine (n = 2), of which 84.6% (n = 11) were male and 15.4% (n = 2) were female, age ≥ 60 y was 61.5% (n = 8) and, significantly, age ≤ 45 y was 15.4% (n = 2). In addition, the majority of isolates were from the ICU (n = 10).

Phenotyping experiments

When comparing growth curves, mucoviscosity assay results, and a G. mellonella infection model, we used the hypervirulent isolate NTUH-K2044. In terms of growth rate, NTUH-K2044 showed the fastest growth rate (Fig. 1 A–C). The other ST15 CRKP isolates displayed distinctly weaker growth rates than NTUH-K2044, while 21081212 displayed a growth rate that was comparable to that of NTUH-K2044. Overnight cultures were centrifuged at low speed for 5 min, and all isolates, including NTUH-K2044, were completely clear in the supernatant at 3 min (Fig. 1D–F). In G. mellonella infection model, isolates 21081212, 21081241 and 21091216 had higher lethality than NTUH-K2044 (Fig. 2 A–C).

Fig. 1
figure 1

Growth curves and mucoviscosity assay of ST15 CRKP isolates. Establishment of growth curves in LB medium to assess the adaptability of ST15 CRKP isolates to the environment (A), (B), and (C) and determination of capsular polysaccharide viscosity using mucoviscosity assay (D), (E), and (F). Hypervirulent isolates NTUH-K2044 was used as a control. CRKP, carbapenem-resistant Klebsiella pneumoniae

Fig. 2
figure 2

ST15 CRKP isolates exhibit a high fatality rate in the G. mellonella infection model. G. mellonella infection model for evaluating the virulence of ST15 CRKP isolates. Nonhypervirulent ST15 CRKP isolates 21073066, 21081241 and 21091216 exhibit higher mortality than the hypervirulent isolates NTUH-K2044 in G. mellonella infection model (A), (B), and (C). CRKP, carbapenem-resistant Klebsiella pneumoniae

Antibiotic resistance profiling

All ST15 CRKP were resistant to amoxicillin/clavulanic acid, ceftriaxone, ceftazidime, cefoperazone/sulbactam, cefuroxime axetil, cefuroxime sodium, cefepime cefoxitin, ertapenem, imipenem, levofloxacin, and piperacillin/tazobactam (except 21122105 which was sensitive to imipenem, minimum inhibitory concentrations [MIC] = 0.25 mg/L), but was sensitive to amikacin, polymyxin B, and tigecycline. In addition, isolates 21081212, 21081241, 2109125 and 21121928 were resistant to trimethoprim/sulfamethoxazole. The distribution of antibiotic resistance is shown in Additional file 1.

Antibiotic resistance genes (ARGs)

The distribution of resistance genes and virulence factors is shown in Fig. 3. A total of 16 resistance genes were detected in all ST15 CRKP, six of which were β-lactams. All ST15 CRKP carried the blaSHV−106 gene (100%). In addition, the isolates carried the carbapenemases-encoding genes blaKPC−2 (69%), the β-lactamases-encoding genes blaLAP−2 (8%), blaTEM−1B (69%) and blaOXA−1 (62%), and the ESBL-encoding genes blaCTX−M−15 (69%). Furthermore, while blaKPC−2 was not present in all ST15 CRKP isolates, but all ST15 isolates were Ertapenem and Imipenem resistant (except 21122105). We also found that all ST15 CRKP isolates carried the gene oqxAB encoding the quinolone efflux pump and the phosphomycin resistance gene fosA [14]. According to previous studies, oqxAB encodes the efflux pump responsible for quinolone resistance, but it cannot be excluded that cephalosporins, carbapenems, and other antibiotics are pumped from the K. pneumoniae cell membrane through this efflux pump [15], while fosA may be widespread in gram-negative bacteria, which is consistent with previous studies [16]. Also tetracycline resistance gene tet(A) (92%), aminoglycoside resistance genes aac(3)-lid (100%) and aac(6’)-lb-cr (69%). In addition, the methicillin resistance gene dfhrA1, the sulfonamide resistance gene sul1, and the macrolide resistance gene mph(A) were also present in a few isolates.

Fig. 3
figure 3

Distribution of resistance genes and virulence factors of ST15 CRKP isolates. The phylogenetic showed that the ST15 CRKP isolates were divided into three subgroups. The resistance gene colour is labelled orange and the virulence factor is blue. Blank spaces indicate that the gene is not present. CRKP, carbapenem-resistant Klebsiella pneumoniae

Virulence factors

We found siderophore coding genes in all ST15 CRKP, including the aerobactin-encoding genes (iutA, 100%), yersiniabactin-encoding genes (ybt, irp1, irp2, and fyuA, 100%), and enterobactin-encoding genes (ent, fepA, 100%). In addition, the multidrug efflux pump acrAB was present in all ST15 CRKP. The hypervirulence-defining genes iucA, iroB, peg-344, rmpA, and rmpA2 were not found in all ST15 CRKP isolates, but the lethality of 21073066, 21081241 and 21091216 was distinctly higher than that of the hypervirulence NTUH-K2044 in the G. mellonella infection model. In previous studies, G. mellonella infection models were frequently used to determine hypervirulent isolates, but because of the phenomenon of apparent overlap in virulence, high G. mellonella lethality does not represent hypervirulence and is not accurate in determining whether it is hypervirulent Klebsiella pneumoniae (hvKP) [17]. In our study, no-hypervirulent isolates also exhibited higher G. mellonella lethality.

Analysis of mobile genetic elements

The sequencing results showed that the insertion elements and transposons of blaSHV−106, blaKPC−2, blaCTX−M−15, blaOXA−1, and blaTEM−1B genes were identical for all isolates (Fig. 4). Both blaSHV−106 are located on chromosomes and inserted into the downstream of lactose operon lac, forming glpR-blaSHV−106-hp-hp-lacY-lacZ-purR-lacI structure. The upstream and downstream of blaKPC−2 are then composed of ISKpn27 and ISKpn6. blaCTX−M−15 forms a Tn2-wbuC-blaCTX−M−15-hp-ISEcp1 with IS elements. blaOXA−1 forms the aacA4-blaOXA−1-cat structure. blaTEM−1B forms the hin-TnAs3-blaTEM−1B-tnpR structure.

Fig. 4
figure 4

The mobile genetic elements of the blaKPC−2, blaTEM−1B, blaSHV−106, blaCTX-M-15, and blaOXA−1 gene of ST15 CRKP are identical. (a) tnpR-ISKpn27-blaKPC−2-ISKpn6-korC-hp-klcA. (b) hin-TnAs3-blaTEM−1B-tnpR. (c) glpR-blaSHV−106-hp-hp-lacY-lacZ-purR-lacI. (d) Tn2-wbuC-blaCTX−M−15-hp-ISEcp1. (e) cat-blaOXA−1-aacA4. CRKP, carbapenem-resistant Klebsiella pneumoniae; hp, hypothetical protein

Phylogenetic analysis

By using BacWGSTdb 2.0 for comparative analysis of 13 ST15 CRKP isolates, single nucleotide polymorphism (SNP) analysis showed a maximum of 993 (21111747 and 21121928) and a minimum of 21 (21080950 and 21103127) (Additional file 2). For the 13 isolates, we constructed a phylogenetic using maximum likelihood based on the core genomic SNPs (Fig. 3), and the results were divided into three subgroups, 21121624, 21091253 and 21122105 with highly homology, 21121928, 21080950, 21080960, 21103127 and 21112561 with highly homology, and 21,081,212, 21,081241 and 21,091,216 with highly homology. To further investigate the genetic relationships of ST15 CRKP isolates, we constructed a global phylogenetic (Fig. 5) using 287 K. pneumoniae from the published genome-wide series of ST15 isolates from China (NCBI), and because there were fewer data available for ST15 isolates, we included all ST15 sequences after excluding unassembled genomes, although they carried different resistance genes. 21121624 and 21122105 are highly homologous to isolate HD006 from Zhejiang, which is located in the same evolutionary branch. 21111747 is highly homologous to isolate ARLG-6699 from an unlabelled region. The other 10 ST15 CRKP isolates in this study were closest to the isolate NJJYY54-C from Nanjing, Jiangsu, which produced KPC-2 and SHV-28.

Fig. 5
figure 5

Phylogenetic construction of 287 isolates of ST15 K. pneumoniae based on core genomic SNPs using Harvest v1.1.2 and further visualisation and modification in iTOL v4. The colour of the outer ring indicates the different regions of the isolates, and the inner ring indicates the different capsular serotypes. The ST15 CRKP in this study is marked in green and other ST15 K. pneumoniae from the Chinese collection of the NCBI database. CRKP, carbapenem-resistant Klebsiella pneumoniae


KPC-2-producing K. pneumoniae was first reported in China in 2007 [18], and since then it has become widespread in China as well as in several countries and regions [19]. It is widely believed that KPC-2-producing ST11 CRKP is the most prevalent isolates in China. However, according to a study, the Chinese ST sequence type is currently shifting from ST11 to ST15, and ST15 showed higher resistance in serocidal assays [20]. ST15 K. pneumoniae is an emerging high-risk clone that has become a serious public health risk and has led to the emergence of ST15 hvKP with the spread of virulent and drug-resistant heterozygous plasmids [9]. In addition, with the widespread use of carbapenems, ST15 CRKP has emerged in recent years in China [21], India [22], Japan [23], and Iran [24] in several places. In this study, we collected 13 ST15 CRKP isolates from July 2021 to December 2021, with more male patients, and the most frequent source of isolates was sputum. Most of the patients had a history of prolonged hospitalisation, invasive procedures and antibiotic therapy, which significantly increased the risk of CRKP fixation [25]. The most frequent source of isolates was still the ICU ward, suggesting that immunocompromise is still the leading cause of infection in patients. It also suggests that hospitals should strengthen in-hospital ward supervision to prevent transmission between patients and health care workers.

In terms of antibiotic resistance, all ST15 CRKP have extremely high rates of resistance to common antibiotics, including amoxicillin/clavulanic acid, ceftriaxone, ceftazidime, cefoperazone/sulbactam, cefuroxime axetil, cefuroxime sodium, cefepime cefoxitin, ertapenem, imipenem, levofloxacin, and piperacillin/tazobactam, This is the same result found in a previous study of ST11 K. pneumoniae. Still, it is noteworthy that all ST15 in this study belonged to MDR, which is significantly higher than ST11 [26]. Meanwhile, according to antibiotic resistance results, we should use antibiotic treatment rationally. ST15 CRKP showed low resistance to amikacin, which is consistent with previous studies [27]. In addition, unsurprisingly, all ST15 CRKP were sensitive to tigecycline and polymyxin B. Regarding phenotypic experiments, we found that ST15 grew slower than NTUH-K2044, which may be related to the presence of siderophores or virulence factors [28]. Mucoviscosity is due to rmpA-regulated rmpD production, a phenotype associated with hvKP isolates [29]. The ST15 CRKP isolate did not detect rmpA and rmpD. However, it is interesting to note that ST15 appears exceptionally lethal in the G. mellonella infection model, which we considered to be due to the presence of overlapping virulence, but whether there are other reasons for this remains to be investigated.

When we analysed the whole genome, the ST15 CRKP isolate carried multiple β-lactamases, including blaKPC−2, blaCTX−M−15, blaSHV−106, blaTEM−1B, and blaOXA−1. Most isolates carried several β-lactamases genes simultaneously, which is consistent with previously reported results that blaTEM, blaSHV, and blaCTX−M (any two or all three) were present simultaneously in K. pneumoniae isolates [15]. OXA-producing ST15 was also found in other regions of China [30]. According to a study, the most common sequences producing ESBL are ST11 and ST15. In our research, ST15 was associated with carbapenemases and ESBL, making treatment more complex [31]. To our knowledge, blaSHV−106 has been rarely reported elsewhere after being registered only in Portugal. However, all STT15 CRKP carried blaSHV−106 in our study. Although SHV-type β-lactamases have been claimed to have little effect on the isolates in some studies, we still need to pay attention to SHV-type β-lactamases [12]. KPC-2 is an important carbapenemase, and the main clone of carbapenem-resistant hypervirulent K. pneumoniae (CR-hvKP) has been reported to be a KPC-2-producing ST11-type sequence in China [32]. However, 69% of ST15 in our study carried KPC-2, and reports suggest that hypervirulent KPC-2-producing ST15 occurs in China [33]. Interestingly, not all isolates carry blaKPC−2, but are resistant to carbapenems, and it is possible that a key role is played by the efflux pump encoded by oqxAB, which is increasingly prevalent in Enterobacteriaceae. Additionally, oqxAB may contribute to the resistance of K. pneumoniae isolates to tigecycline [34]. We found that all ST15 CRKP carry fosA, and the concomitant relevance of fosA is higher in KPC-2-producing K. pneumoniae. The combination of fosA and blaKPC−2 carried by plasmids accelerates the spread of resistance genes, and therefore fosfomycin should be used with caution for treating CRKP [35]. ESBL is the main cause of resistance to β-lactam antibiotics, and CTX-M-type enzymes have replaced TEM and SHV as the most common ESBL [11]. CTX-M-15 differs from CTX-M-3 in that a single amino acid is mutated and exhibits increased resistance to ceftazidime [36]. According to studies, ST15 CRKP often carries blaCTX−M−15 [27], and in the present study, 69% of ST15 CRKP isolates carried blaCTX−M−15. In addition, OXA-1 was another common β-lactamase in this study. OXA-1 type enzymes play an important role in hydrolysis of cefepime [37].

For virulence factors, we found that ST15 CRKP carried genes encoding aerobactin, enterobactin, and yersiniabactin, including iutA, ybt, irp1, irp2, fyuA, ent, fepA, that are essential for bacterial growth. According to previous studies, siderophores systems, such as aerobactin, yersiniabactin, and enterobactin, are more common in invasive isolates than in non-invasive isolates [38]. Although yersiniabactin was detected in nearly 30% of the non-invasive isolates and almost 80% of the bacteraemia isolates, we detected it in 100% of the ST15 CRKP. On the other hand, the ICEkp locus, where ybt is located, is a common mobile genetic element of K. pneumoniae [39]. The efflux pump, acrAB, is also critical for acquiring antibiotic resistance in gram-negative bacteria. Tigecycline and ciprofloxacin could be effectively removed by the efflux pump acrAB. However, carbapenems, some cephalosporins, and aminoglycosides cannot be removed by the pump [40]. We further analysed the genetic environment of the resistance genes. We found that the genetic environment around blaKPC−2, blaSHV−106, blaCTX−M−15, blaOXA−1, and blaTEM−1B are identical in ST15, upstream, and downstream of blaKPC−2 are ISKpn27 and ISKpn6, suggesting that the resistance genes may be transmitted via plasmids [41]. We found that the ST15 CRKP isolates formed three subgroups when we performed a phylogenetic analysis, implying that there may be clonal transmission between them. ST15 CRKP isolates were shown to be highly homologous to isolates from Jiangsu and Zhejiang in further analysis, suggesting that ST15 CRKP may have spread widely in East China.

There were limitations to this research, firstly, we were unable to consistently collect more ST15 CRKP from this hospital and secondly, we did not analysis the types of plasmids carried by ST15 CRKP due to the limitations of using second generation sequencing technology.


In conclusion, we report outbreak of ST15 CRKP in a tertiary hospital in Anhui, China, which was phenotypically and genomically analysed. ST15 CRKP isolates are extremely resistant to commonly used antibiotics and carried multiple β-lactamase genes, and carried multiple siderophores encoding genes and acrAB and oqxAB efflux pumps, which may play an essential role in the virulence and resistance of ST15 CRKP isolates. Additionally, it is suggested by the phylogeny that ST15 CRKP may have spread widely in localised areas. Therefore, nosocomial MDR and carbapenem-resistant K. pneumoniae should be continuously monitored to prevent their evolution to highly virulent resistance through the acquisition of virulence factors carried by plasmids or removable genetic elements.


Sources and identification of bacterial isolates

A total of 13 MDR K. pneumoniae isolates from different patients from the clinical microbiology laboratory of Anhui Provincial Hospital (Anhui, China) were collected between July 2021 and December 2021. The VITEK 2 Compact System (bioMérieux, France) was used to identify the isolates. All isolates were processed according to standard operating procedures, scribed in a sterile environment onto 5% sheep blood agar plates and cultured at 37 °C.

Antibiotic susceptibility testing

The MICs of Amikacin, Amoxicillin/Clavulanic acid, Ceftriaxone, Ceftazidime, Cefoperazone/Sulbactam, Cefuroxime axetil, Cefuroxime sodium, Cefuroxime, Cefepime, Cefoxitin, Ertapenem, Imipenem, Levofloxacin, Piperacillin/Tazobactam, Trimethoprim/Sulfamethoxazole were determined by the VITEK 2 Compact System and the results of the antimicrobial susceptibility tests were interpreted according to the Clinical Laboratory Standards Institute (CLSI) [42]. As previously described [43], the MIC of polymyxin B and tigecycline was determined by broth dilution using Mueller-Hinton broth and the results were analysed according to The European Committee on Antimicrobial Susceptibility Testing (EUCAST,

Growth curves

To study the environmental adaptability of the ST15 CRKP isolates, growth curves were measured in LB medium. As previously described [44], overnight cultures were diluted to 0.02 OD600/mL and 150 µL was pipetted into 96-well plates and incubated at 37 °C, measured every 0.5 h using an enzyme marker and recorded until the curve plateaued.

Mucoviscosity assay

To study the viscosity of ST15 CRKP capsular polysaccharide, we measured its supernatant by low speed centrifugation [45]. Overnight cultures were diluted to 1 OD600/ mL and centrifuged at 2, 350 x g for 5 min and the supernatant was measured at OD600 per minute.

Galleria mellonella infection model

Assessment of virulence of ST15 CRKP isolates using G. mellonella infection model [46]. Select G. mellonella larvae that are between 250 and 300 mg in size and free of pathogens for reserve (Tianjin Huiyude Biotechnology Co., Ltd.). Overnight bacterial cultures were diluted to 108 CFU/mL using sterile saline, and 10 µL of diluted bacterial solution was injected into the centre of the second gastropod of the larvae using a microsyringe (100 µL). Sterile saline and the hvKP isolate NTUH-K2044 were injected as negative and positive controls, respectively. After injection, larvae were incubated in the dark at 37 °C and mortality was observed and recorded at 12 h intervals for 72 h. Three parallel groups were set up for each isolates.

Capsular serology typing and MLST

Capsular typing was performed by PCR amplification using wzi PCR primers, MLST was performed by PCR amplification of seven pairs of housekeeping genes (rpoB, gapA, mdh, pgi, phoE, infB and tonB) of K. pneumoniae, ST sequences and capsular typing are available for comparison in the database (

Whole genome sequencing (WGS), assembly, and annotation

WGS of K. pneumoniae was performed using an Illumina HiSeq 4000 platform in Genewiz (Anhui, China). Firstly, whole genomic DNA was extracted from the samples to be tested and libraries were constructed for cluster preparation and sequencing. The raw sequencing data (Pass Filter Data) was removed using cutadapt version 1.9.1 [47] to remove junctions and low quality sequences, followed by k-mer analysis using Velvet version 1.2.10 [48], and de Brujin plots were constructed using the overlap between k-mer. The scaffold sequences were further assembled from the contig sequences using pairwise relationships between Paired end reads and insert size distances using SSPACE version 3.0 [49]. Finally, GapFiller version 10 [50] was used to match all the library sequencing reads back to the scaffold sequence, and the gaps in the scaffold sequence were completed using the matched reads, and the scaffold sequence was extended. Genome assembly by unicycler version 0.4.9 [51] and annotated using the rapid prokaryotic genome annotation tool, Prokka version 1.14.6 [52].

Genome analysis and phylogenetic construction

Acquired ARGs were identified using ABRicate version1.0.1 ( by aligning the genomic sequences to the ResFinder database [53]. The virulence factors of the isolates were identified using ABRicate version 1.0.1 by aligning the genomic sequences to the VFDB database [54]. The typing results were further determined using multilocus-sequence typing was performed by MLST 2.1 ( The HarvestTools kit (Parsnp, Gingr and HarvestTools) [55] and BacWGSTdb [56] were used to perform a comparative genomic analysis and phylogenetic analysis on the different isolates, and further visualisation and modification in iTOL v4 ( [57].

Statistical analysis

Growth curves, mucoviscosity assay, and G. mellonella infection model data were statistically analysed and expressed as mean standard deviation or percentage using GraphPad Prism 7.0 ( All experiments were repeated three times independently.

Availability of data and materials

The datasets used during the current study are available from the corresponding author upon reasonable request. Whole Genome Sequencing(WGS) has been uploaded to NCBI with the BioProject accession number PRJNA823907.



Carbapenem-resistant Klebsiella pneumoniae


Whole genome sequencing


Multidrug resistant


Extended-spectrum beta-lactamases


World Health Organisation


Multilocus-sequence typing


Hypervirulent Klebsiella pneumoniae


classical K. pneumoniae


Polymerase chain reaction


  1. Cubero M, Grau I, Tubau F, Pallarés R, Dominguez MA, Linares J, et al. Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007–2013). Clin Microbiol Infect. 2016;22:154–60.

    Article  PubMed  CAS  Google Scholar 

  2. Wyres KL, Wick RR, Judd LM, Froumine R, Tokolyi A, Gorrie CL, et al. Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae. PLoS Genet. 2019;15:e1008114.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, et al. Comparative review of the carbapenems. Drugs. 2007;67:1027–52.

    Article  PubMed  CAS  Google Scholar 

  4. Chen R, Liu Z, Xu P, Qi X, Qin S, Wang Z, et al. Deciphering the epidemiological characteristics and molecular features of bla KPC-2- or bla NDM-1-positive Klebsiella pneumoniae isolates in a newly established hospital. Front Microbiol. 2021;12:741093.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318–27.

    Article  PubMed  Google Scholar 

  6. Zheng B, Dai Y, Liu Y, Shi W, Dai E, Han Y, et al. Molecular epidemiology and risk factors of carbapenem-resistant Klebsiella pneumoniae infections in eastern China. Front Microbiol. 2017;8:1061.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228–36.

    Article  PubMed  CAS  Google Scholar 

  8. Hu Y, Liu C, Shen Z, Zhou H, Cao J, Chen S, et al. Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008–2018. Emerg Microbes Infect. 2020;9:1771–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Li R, Cheng J, Dong H, Li L, Liu W, Zhang C, et al. Emergence of a novel conjugative hybrid virulence multidrug-resistant plasmid in extensively drug-resistant Klebsiella pneumoniae ST15. Int J Antimicrob Agents. 2020;55:105952.

    Article  PubMed  CAS  Google Scholar 

  10. Rahim AA, Ali Mohamed KA. AM. Prevalence of extended spectrum beta-lactamase-producing Klebsiella pneumoniae in clinical isolates. Jundishapur J Microbiol. 2014;7:e17114.

    Google Scholar 

  11. Castanheira M, Simner PJ, Bradford PA. Extended-spectrum beta-lactamases: an update on their characteristics, epidemiology and detection. JAC Antimicrob Resist. 2021;3:dlab092.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Mendonca N, Ferreira E, Louro D, Participants AR, Caniça M. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal. Int J Antimicrob Agents. 2009;34:29–37.

    Article  PubMed  CAS  Google Scholar 

  13. Berglund B, Hoang NT, Tärnberg M, Le NK, Nilsson M, Khu DT, et al. Molecular and phenotypic characterization of clinical isolates belonging to a KPC-2-producing strain of ST15 Klebsiella pneumoniae from a Vietnamese pediatric hospital. Antimicrob Resist Infect Control. 2019;8:156.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kim HB, Wang M, Park CH, Kim EC, Jacoby GA, Hooper DC. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother. 2009;53:3582–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Yu X, Zhang W, Zhao Z, Ye C, Zhou S, Wu S, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance. BMC Genomics. 2019;20:822.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ito R, Mustapha MM, Tomich AD, Callaghan JD, McElheny CL, Mettus RT, et al. Widespread fosfomycin resistance in gram-negative bacteria attributable to the chromosomal fosA gene. mBio. 2017;8.

  17. Russo TA, MacDonald U. The Galleria mellonella infection model does not accurately differentiate between hypervirulent and classical Klebsiella pneumoniae. mSphere. 2020;5.

  18. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007;51:763–5.

    Article  PubMed  CAS  Google Scholar 

  19. Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, et al. Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine. 2017;19:98–106.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Chen J, Hu C, Wang R, Li F, Sun G, Yang M, et al. Shift in the dominant sequence type of carbapenem-resistant Klebsiella pneumoniae bloodstream infection from ST11 to ST15 at a medical center in northeast China, 2015–2020. Infect Drug Resist. 2021;14:1855–63.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Li X, Ma W, Qin Q, Liu S, Ye L, Yang J, et al. Nosocomial spread of OXA-232-producing Klebsiella pneumoniae ST15 in a teaching hospital, Shanghai, China. BMC Microbiol. 2019;19:235.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Naha S, Sands K, Mukherjee S, Saha B, Dutta S, Basu S. OXA-181-like carbapenemases in Klebsiella pneumoniae ST14, ST15, ST23, ST48, and ST231 from septicemic neonates: coexistence with NDM-5, resistome, transmissibility, and genome diversity. mSphere. 2021;6.

  23. Soliman AM, Nariya H, Tanaka D, Yu L, Hisatsune J, Kayama S, et al. Vegetable-derived carbapenemase-producing high-risk Klebsiella pneumoniae ST15 and Acinetobacter baumannii ST2 clones in Japan: coexistence of bla NDM-1, bla OXA-66, bla OXA-72, and an AbaR4-like resistance island in the same sample. Appl Environ Microbiol. 2021;87.

  24. Davoudabadi S, Goudarzi H, Goudarzi M, Ardebili A, Faghihloo E, Sharahi JY, et al. Detection of extensively drug-resistant and hypervirulent Klebsiella pneumoniae ST15, ST147, ST377 and ST442 in Iran. Acta Microbiol Immunol Hung. 2021.

  25. Qin X, Wu S, Hao M, Zhu J, Ding B, Yang Y, et al. The colonization of carbapenem-resistant Klebsiella pneumoniae: epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis. 2020;221:206-14.

    Article  Google Scholar 

  26. Xiao S, Chen T, Wang H, Zeng Q, Chen Q, Yang Z, et al. Drug susceptibility and molecular epidemiology of Klebsiella pneumoniae bloodstream infection in ICU patients in Shanghai, China. Front Med (Lausanne). 2021;8:754944.

    Article  Google Scholar 

  27. Han Y, Huang L, Liu C, Huang X, Zheng R, Lu Y, et al. Characterization of carbapenem-resistant Klebsiella pneumoniae ST15 clone coproducing KPC-2, CTX-M-15 and SHV-28 spread in an intensive care unit of a tertiary hospital. Infect Drug Resist. 2021;14:767–73.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Heiden SE, Hübner NO, Bohnert JA, Heidecke CD, Kramer A, Balau V, et al. A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition. Genome Med. 2020;12:113.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Russo TA, MacDonald U, Hassan S, Camanzo E, LeBreton F, Corey B, et al. An assessment of siderophore production, mucoviscosity, and mouse infection models for defining the virulence spectrum of hypervirulent Klebsiella pneumoniae. mSphere. 2021;6.

  30. Shi Q, Han R, Guo Y, Zheng Y, Yang Y, Yin D, et al. Emergence of ST15 Klebsiella pneumoniae clinical isolates producing plasmids-mediated RmtF and OXA-232 in China. Infect Drug Resist. 2020;13:3125–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Xiao SZ, Wang S, Wu WM, Zhao SY, Gu FF, Ni YX, et al. The resistance phenotype and molecular epidemiology of Klebsiella pneumoniae in bloodstream infections in Shanghai, China, 2012–2015. Front Microbiol. 2017;8:250.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zhang Y, Jin L, Ouyang P, Wang Q, Wang R, Wang J, et al. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis. J Antimicrob Chemother. 2020;75:327–36.

    Article  PubMed  CAS  Google Scholar 

  33. Wang Y, Lan W, Yang W, Jiang Y, Qi Y. Molecular characterization of a hypermucoviscous, hypervirulent, and carbapenem-resistant ST15/K19 Klebsiella pneumoniae clone from human infection. J Glob Antimicrob Resist. 2022;31:80–1.

    Article  PubMed  CAS  Google Scholar 

  34. Cheng L, Cao XL, Zhang ZF, Ning MZ, Xu XJ, Zhou W, et al. Clonal dissemination of KPC-2 producing Klebsiella pneumoniae ST11 clone with high prevalence of oqxAB and rmtB in a tertiary hospital in China: results from a 3-year period. Ann Clin Microbiol Antimicrob. 2016;15:1.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Zhou H, Zhang K, Chen W, Chen J, Zheng J, Liu C, et al. Epidemiological characteristics of carbapenem-resistant Enterobacteriaceae collected from 17 hospitals in Nanjing district of China. Antimicrob Resist Infect Control. 2020;9:15.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Poirel L, Gniadkowski M, Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. J Antimicrob Chemother. 2002;50:1031–4.

    Article  PubMed  CAS  Google Scholar 

  37. Dubois V, Arpin C, Quentin C, Texier-Maugein J, Poirel L, Nordmann P. Decreased susceptibility to cefepime in a clinical strain of Escherichia coli related to plasmid- and integron-encoded OXA-30 beta-lactamase. Antimicrob Agents Chemother. 2003;47:2380–1.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Cienfuegos-Gallet AV, Zhou Y, Ai W, Kreiswirth BN, Yu F, Chen L. Multicenter genomic analysis of carbapenem-resistant Klebsiella pneumoniae from bacteremia in China. Microbiol Spectr. 2022;10:e0229021.

    Article  PubMed  Google Scholar 

  39. Lam MM, Wick RR, Wyres KL, Gorrie CL, Judd LM, Jenney AW, et al. Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element ICEKp in Klebsiella pneumoniae populations. Microb Genom. 2018;4.

  40. Li J, Xu Q, Ogurek S, Li Z, Wang P, Xie Q, et al. Efflux pump AcrAB confers decreased susceptibility to piperacillin-tazobactam and ceftolozane-tazobactam in tigecycline-non-susceptible Klebsiella pneumoniae. Infect Drug Resist. 2020;13:4309–19.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. de Souza RC, Dabul AN, dos Santos Boralli CM, Zuvanov L, da Cunha Camargo IL. Dissemination of blaKPC-2 in an NTEKPC by an IncX5 plasmid. Plasmid. 2019;106:102446.

    Article  PubMed  Google Scholar 

  42. Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100. J Clin Microbiol. 2021;59:e00213-21.

    Article  PubMed Central  Google Scholar 

  43. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3:163–75.

    Article  PubMed  CAS  Google Scholar 

  44. Krishnamurthi VR, Niyonshuti II, Chen J, Wang Y. A new analysis method for evaluating bacterial growth with microplate readers. PLoS ONE. 2021;16:e0245205.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Walker KA, Miner TA, Palacios M, Trzilova D, Frederick DR, Broberg CA, et al. A Klebsiella pneumoniae regulatory mutant has reduced capsule expression but retains hypermucoviscosity. mBio. 2019;10.

  46. Insua JL, Llobet E, Moranta D, Pérez-Gutiérrez C, Tomás A, Garmendia J, et al. Modeling Klebsiella pneumoniae pathogenesis by infection of the wax moth Galleria mellonella. Infect Immun. 2013;81:3552–65.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  47. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. 2011;17:3.

  48. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008;18:821–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Boetzer M, Henkel CV, Jansen HJ, Butler D, Pirovano W. Scaffolding pre-assembled contigs using SSPACE. Bioinformatics. 2011;27:578–9.

    Article  PubMed  CAS  Google Scholar 

  50. Nadalin F, Vezzi F, Policriti A. GapFiller: a de novo assembly approach to fill the gap within paired reads. BMC Bioinformatics. 2012;13(Suppl 14):8.

    Article  Google Scholar 

  51. Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13:e1005595.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30:2068–9.

    Article  PubMed  CAS  Google Scholar 

  53. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67:2640–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  54. Wyres KL, Wick RR, Gorrie C, Jenney A, Follador R, Thomson NR, et al. Identification of Klebsiella capsule synthesis loci from whole genome data. Microb Genom. 2016;2:e000102.

    PubMed  PubMed Central  Google Scholar 

  55. Treangen TJ, Ondov BD, Koren S, Phillippy AM. The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol. 2014;15:524.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Feng Y, Zou S, Chen H, Yu Y, Ruan Z. BacWGSTdb 2.0: a one-stop repository for bacterial whole-genome sequence typing and source tracking. Nucleic Acids Res. 2021;49:D644-50.

    Article  Google Scholar 

  57. Letunic I, Bork P. Interactive Tree Of Life (iTOL) v4: recent updates and new developments. Nucleic Acids Res. 2019;47:W256-9.

    Article  Google Scholar 

Download references


Not applicable.


This research was supported by the National Key Research and Development Programme of China (2021YFC2300300), the Strategic Priority Research Programme of the Chinese Academy of Sciences (XDB29020000), the Fundamental Research Funds for the Central Universities (YD9100002013) and grants from National Natural Science Foundation of China (32070132).

Author information

Authors and Affiliations



BS and ZH designed the project. HZ performed the experiments. ZH collected isolates. ZH analysed the data. HZ wrote the manuscript. YL, ZH, and BS critically revised the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Zhien He, Yujie Li or Baolin Sun.

Ethics declarations

Ethics approval and consent to participate

All isolates in this study were collected during the bacteriological analysis in the clinical microbiology laboratory of a public hospital, and patients were treated anonymously and therefore did not require ethical approval.

Consent for publication

Not applicable.

Competing interests

The authors have no conflicts of interest to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhao, H., He, Z., Li, Y. et al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae ST15 of producing KPC-2, SHV-106 and CTX-M-15 in Anhui, China. BMC Microbiol 22, 262 (2022).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI:


  • Carbapenem-resistant Klebsiella pneumoniae
  • ST15 Klebsiella pneumoniae
  • Antibiotic resistance
  • β-lactams
  • Whole genome sequencing (WGS)
  • Virulence factors